| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.629 | 12.638 | 14.170 | 12.790 | 14.167 | 7.275 | 8.873 | 14.088 | 13.428 | 14.856 |
| Total Income - EUR | 11.629 | 12.638 | 14.170 | 12.790 | 14.167 | 8.522 | 8.055 | 14.088 | 13.429 | 14.856 |
| Total Expenses - EUR | 5.968 | 5.214 | 5.264 | 6.562 | 7.899 | 10.015 | 12.091 | 7.312 | 9.632 | 14.756 |
| Gross Profit/Loss - EUR | 5.661 | 7.424 | 8.906 | 6.228 | 6.268 | -1.493 | -4.036 | 6.776 | 3.797 | 100 |
| Net Profit/Loss - EUR | 5.312 | 7.080 | 8.481 | 5.844 | 5.714 | -1.697 | -4.302 | 6.362 | 3.201 | 34 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oftaprax Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 57 | 72 | 32 | 1.881 | 2.392 | 1.713 | 1.135 | 613 | 274 | 0 |
| Current Assets | 2.310 | 7.458 | 9.102 | 4.447 | 4.017 | 3.229 | 374 | 7.082 | 9.827 | 9.879 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 41 | 51 | 8 | 18 | 0 | 837 | 20 | 0 | 22 | 424 |
| Cash | 2.269 | 7.407 | 9.094 | 4.429 | 4.017 | 2.392 | 354 | 7.082 | 9.804 | 9.455 |
| Shareholders Funds | 2.174 | 7.348 | 8.743 | 6.102 | 5.967 | 4.157 | -237 | 6.124 | 9.307 | 9.288 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 193 | 183 | 390 | 226 | 441 | 785 | 1.746 | 1.570 | 794 | 741 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftaprax Srl